Cellular localization and expression patterns of interleukin‐10, interleukin‐4, and their receptors in multiple sclerosis lesions
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Cytokines have been shown to play a crucial role in the pathogenesis of multiple sclerosis (MS). However, still limited data are available on the expression of anti‐inflammatory cytokines within the central nervous system (CNS) during MS lesion development. Therefore, we have examined the expression of the anti‐inflammatory cytokines, interleukin‐10 (IL‐10) and IL‐4, and their specific receptors, IL‐10R and IL‐4R, in postmortem human brain tissue obtained from MS patients. Specific patterns of protein localization and expression for both proteins could be observed within active and chronic MS lesions. Strongest IL‐10 immunoreactivity was observed in reactive astrocytes within active demyelinating lesions and the hypercellular rim of chronic active MS lesions. Moreover, perivascular macrophages were immunoreactive for IL‐10 in (chronic) active MS lesions. Most intense IL‐4 immunoreactivity was detected in reactive fibrillary astrocytes within the hypocellular regions of chronic active and chronic inactive MS lesions. Strong immunoreactivity for IL‐10R and IL‐4R was detected on macrophages in both parenchymal and perivascular areas and on reactive astrocytes in active and chronic MS lesions. Our results indicate that IL‐10 and IL‐4 have an active role in CNS immune responses. The specific patterns of protein localization and protein expression for both IL‐10 and IL‐4 in MS lesions at different stages of development suggest that these anti‐inflammatory cytokines and their receptors participate in processes leading to the formation of chronic MS lesions. GLIA 38:24–35, 2002. © 2002 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Exacerbations of multiple sclerosis in patients treated with gamma interferon
Panitch, H., Haley, A., Hirsch, R., & Johnson, K. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92863-7 · Cited by 1,071 · cited 1×
“…cytokines and/or drugs inducing the production of anti-inflammatory cytokines, have been variably attempted over time in MS in order to target proinflammatory cytokines therapeutically (Panitch et al., 1987; Barkhof and Polman, 1997; Smith et al., 1997; Calabresi et al., 1998; Rudick et al., 1998).”
Background
Cited by
Neuroinflammation and M2 Microglia: The Good, the Bad, and the Inflamed
Cherry, J. D., Olschowka, J. A., & O’Banion, M. K. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-98 · Cited by 1,748
“Even though the activity of peripheral cells is not clear, endogenous cells like astrocytes and microglia have been observed to secrete IL-4 or IL-10 during pathological conditions [153].”
BackgroundT cell subsets and their signature cytokines in autoimmune and inflammatory diseases
Raphael, I., Nalawade, S., Eagar, T. N., & Forsthuber, T. G. (2015) · Cytokine · doi:10.1016/j.cyto.2014.09.011 · Cited by 1,160
IL-4 in the brain: a cytokine to remember
Gadani, S. P., Cronk, J. C., Norris, G. T., & Kipnis, J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1202246 · Cited by 549
Balancing the immune response in the brain: IL-10 and its regulation
Lobo-Silva, D., Carriche, G. M., Castro, A. G., Roque, S., & Saraiva, M. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0763-8 · Cited by 429
Ponomarev, E. D., Maresz, K., Tan, Y., & Dittel, B. N. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1922-07.2007 · Cited by 396
“Another potential cellular source is astrocytes (Hulshof et al., 2002).”
Astrocytes in the Epileptic Brain
Wetherington, J., Serrano, G., & Dingledine, R. (2008) · Neuron · doi:10.1016/j.neuron.2008.04.002 · Cited by 389
Lymphocytes as a neural probe: potential for studying psychiatric disorders
Gladkevich, A., Kauffman, H. F., & Korf, J. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.01.009 · Cited by 360
The Role of Astrocytes in Multiple Sclerosis
Ponath, G., Park, C., & Pitt, D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00217 · Cited by 359
Neuropathic pain and cytokines: current perspectives
Malcangio, M., Clark, A. K., & Old, E. A. (2013) · Journal of Pain Research · doi:10.2147/jpr.s53660 · Cited by 337
Microglia: gatekeepers of central nervous system immunology
Tambuyzer, B. R., Ponsaerts, P., & Nouwen, E. J. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0608385 · Cited by 331
Commentary: IL-4 and IL-13 receptors and signaling
McCormick, S. M., & Heller, N. M. (2015) · Cytokine · doi:10.1016/j.cyto.2015.05.023 · Cited by 317
Theiler's Virus Infection: a Model for Multiple Sclerosis
Oleszak, E. L., Chang, J. R., Friedman, H., Katsetos, C. D., & Platsoucas, C. D. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.1.174-207.2004 · Cited by 308
Cytokines: Powerful Regulators of Glial Cell Activation
John, G. R., Lee, S. C., & Brosnan, C. F. (2003) · The Neuroscientist · doi:10.1177/1073858402239587 · Cited by 300
Brambilla, R. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-01980-7 · Cited by 246
The therapeutic potential of interleukin-10 in neuroimmune diseases
Kwilasz, A. J., Grace, P. M., Serbedzija, P., Maier, S. F., & Watkins, L. R. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.10.020 · Cited by 227
“In the central nervous system (CNS), IL-10 is expressed by microglia, astrocytes and neurons (Gutierrez et al., 2014; Hulshof et al., 2002; Kettenmann et al., 2011; Ledeboer et al., 2002; Tarazi et al., 2014b; Taruc-Uy and Lynch, 2013; Yan et al., 2014).”
BackgroundControl of autoimmune CNS inflammation by astrocytes
Rothhammer, V., & Quintana, F. J. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0515-3 · Cited by 214
Altered expression patterns of group I and II metabotropic glutamate receptors in multiple sclerosis
Geurts, J. J. G. (2003) · Brain · doi:10.1093/brain/awg179 · Cited by 194
“The classi®cation of the lesions was based on extensive analysis of the distribution of in ̄ammatory cells, T cells, macrophages and astrocytes, and on the presence of active myelin breakdown, as previously reported (van der Valk and De Groot, 2000; Hulshof et al., 2002).”
BackgroundMethodMeeuwsen, S., Persoon‐Deen, C., Bsibsi, M., Ravid, R., & Noort, J. M. V. (2003) · Glia · doi:10.1002/glia.10259 · Cited by 185
Peferoen, L. A. N., Vogel, D. Y. S., Ummenthum, K., Breur, M., Heijnen, P. D. A. M., Gerritsen, W. H., Peferoen-Baert, R. M. B., van der Valk, P., Dijkstra, C. D., & Amor, S. (2015) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000149 · Cited by 178
“Although IL-4 has been described in MS lesions (64, 65), it is not detected by immunohistochemistry in preactive lesions (3).”
BackgroundThe cytokine temporal profile in rat cortex after controlled cortical impact
Dalgard, C. L., Cole, J. T., Kean, W. S., Lucky, J. J., Sukumar, G., McMullen, D. C., Pollard, H. B., & Watson, W. D. (2012) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2012.00006 · Cited by 121
Astroglial‐derived lymphotoxin‐α exacerbates inflammation and demyelination, but not remyelination
Plant, S. R., Arnett, H. A., & Ting, J. P. (2005) · Glia · doi:10.1002/glia.20089 · Cited by 60
“In vitro studies have demonstrated a cytotoxic role for TNF and Lt on oligodendrocytes (Selmaj et al., 1991b; Plo et al., 1999; Cammer, 2002; Jurewicz et al., 2003).”
BackgroundDendritic Cell Differentiation Signals Induce Anti-Inflammatory Properties in Human Adult Microglia
Lambert, C., Desbarats, J., Arbour, N., Hall, J. A., Olivier, A., Bar-Or, A., & Antel, J. P. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.12.8288 · Cited by 50
Metadata
- Authors
- Hulshof, S., Montagne, L., De Groot, C. J. A., & Van Der Valk, P.
- Venue
- Glia
- Publisher
- Wiley
- Published
- 2002-02-15
- Volume
- 38
- Issue
- 1
- Pages
- 24-35
- ISSN
- 0894-1491 (ISSN-L)
- 1098-1136
- OpenAlex
- W2116072148
- Cited by
- 140
- References
- 1
- FWCI
- 5.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.